These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18675185)

  • 1. [HIV and hepatitis C virus coinfection].
    Cacoub P; Sène D; Rosenthal E; Pol S
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S82-9. PubMed ID: 18675185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of chronic hepatitis C virus infection in HIV-infected patients.
    Pol S; Soriano V
    Clin Infect Dis; 2008 Jul; 47(1):94-101. PubMed ID: 18513148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia in the treatment of hepatitis C virus infection.
    Sulkowski MS
    Clin Infect Dis; 2003; 37 Suppl 4():S315-22. PubMed ID: 14582000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of HIV and hepatitis B coinfection.
    Matthews G
    Curr Opin Infect Dis; 2007 Feb; 20(1):16-21. PubMed ID: 17197877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
    Verucchi G; Calza L; Manfredi R; Chiodo F
    Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4.
    Soriano V; Núñez M; Sánchez-Conde M; Barreiro P; García-Samaniego J; Martín-Carbonero L; Romero M; González-Lahoz J
    Antivir Ther; 2005; 10(1):167-70. PubMed ID: 15751774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of inosine triphosphatase gene variants on the risk of anemia in HIV/hepatitis C virus-coinfected patients treated for chronic hepatitis C.
    Rallón NI; Morello J; Labarga P; Benito JM; Rodríguez-Nóvoa S; Vispo E; Barreiro P; Castro MÁ; Aguirrebengoa K; Pineda JA; Miralles P; Tellez MJ; Portu J; Miralles C; Ocampo A; Soriano V;
    Clin Infect Dis; 2011 Dec; 53(12):1291-5. PubMed ID: 22028438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
    Rodríguez-Torres M
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1117-28. PubMed ID: 23199398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on drug interactions: the challenge of treating hepatitis C virus infection with direct-acting antiviral drugs in the HIV-positive patient.
    Rodríguez-Torres M
    Curr Opin Infect Dis; 2013 Feb; 26(1):50-7. PubMed ID: 23242341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should HIV/HCV coinfected patients with severe hepatitis be treated for hepatitis C.
    Rockstroh JK
    Presse Med; 2005 Nov; 34(20 Pt 2):1585-8. PubMed ID: 16314818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coinfection with HIV and HCV: abacavir and ribavirine, why not?].
    Valencia ME; Moreno V
    Rev Clin Esp; 2012 Jan; 212(1):26-30. PubMed ID: 21839993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis C in patients coinfected by human immunodeficiency virus].
    Sánchez-Quijano A; Leal M; Lissen E
    Gastroenterol Hepatol; 2002; 25(6):423-31. PubMed ID: 12069706
    [No Abstract]   [Full Text] [Related]  

  • 20. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005).
    Nelson M; Matthews G; Brook MG; Main J; ;
    HIV Med; 2005 Jul; 6 Suppl 2():96-106. PubMed ID: 16011539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.